BlackRock Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

BlackRock Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$486K	Buy	53,615 +40,000	+294%	+$372K	﹤0.01%	2220
2016 Q3	$126K	Hold	13,615	–	–	﹤0.01%	2916
2016 Q2	$139K	Sell	13,615 -465,220	-97%	-$4.26M	﹤0.01%	2799
2016 Q1	$4.33M	Buy	478,835 +216,755	+83%	+$1.94M	﹤0.01%	1150
2015 Q4	$2.43M	Buy	262,080 +244,965	+1,431%	+$2.68M	﹤0.01%	1339
2015 Q3	$219K	Hold	17,115	–	–	﹤0.01%	2671
2015 Q2	$189K	Buy	+17,115	New	+$189K	﹤0.01%	2822
2015 Q1	–	Sell	-385,590	Closed	-$3.89M	–	3654
2014 Q4	$3.89M	Sell	385,590 -313,315	-45%	-$3.3M	﹤0.01%	1032
2014 Q3	$7.34M	Sell	698,905 -24,310	-3%	-$229K	0.01%	869
2014 Q2	$6.24M	Sell	723,215 -762,390	-51%	-$6.41M	0.01%	912
2014 Q1	$13M	Buy	1,485,605 +221,500	+18%	+$1.93M	0.01%	701
2013 Q4	$10.4M	Buy	1,264,105 +415,120	+49%	+$3.29M	0.01%	780
2013 Q3	$6.42M	Buy	848,985 +148,300	+21%	+$1.08M	0.01%	915
2013 Q2	$5.3M	Buy	+700,685	New	+$5.12M	0.01%	944

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

BlackRock Advisors's RDY Position: Q4 2016 in Review

BlackRock Advisors increased its Dr. Reddy's Laboratories (RDY) stake by 294% in Q4 2016, buying an estimated $372K and bringing the position to 53,615 shares worth $486K. The position accounts for ﹤0.01% of the portfolio, ranked #2220.

BlackRock Advisors first reported a position in RDY in Q2 2013 and has held it in 14 quarters since. The position peaked at $13M in Q1 2014. 164 funds tracked by Wall St. Rank hold RDY as of Q4 2016.

BlackRock Advisors held 53,615 shares of Dr. Reddy's Laboratories worth $486K as of Q4 2016.
BlackRock Advisors bought 40,000 Dr. Reddy's Laboratories shares in Q4 2016, an estimated $372K.
Dr. Reddy's Laboratories made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #2220 holding.
BlackRock Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 14 quarters since.
BlackRock Advisors's Dr. Reddy's Laboratories position peaked at $13M in Q1 2014.
164 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.